|
1
|
Benjamin RS: Adjuvant and neoadjuvant
chemotherapy for osteosarcoma: A historical perspective. Adv Exp
Med Biol. 1257:1–10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Garcia MB, Ness KK and Schadler KL:
Exercise and physical activity in patients with osteosarcoma and
survivors. Adv Exp Med Biol. 1257:193–207. 2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Anderson PM: Radiopharmaceuticals for
treatment of osteosarcoma. Adv Exp Med Biol. 1257:45–53.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kiany S, Harrison D and Gordon N: The
histone deacetylase inhibitor Entinostat/Syndax 275 in
osteosarcoma. Adv Exp Med Biol. 1257:75–83. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Li Z, Liu S, Li X, Zhao W, Li J and Xu Y:
Circular RNA in Schizophrenia and depression. Front psychiatry.
11(392)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Meng L, Ding P, Liu S, Li Z, Sang M and
Shan B: The emerging prospects of circular RNA in tumor immunity.
Ann Transl Med. 8(1091)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jiang X and Chen D: Circular RNA
hsa_circ_0000658 inhibits osteosarcoma cell proliferation and
migration via the miR-1227/IRF2 axis. J Cell Mol Med. 25:510–520.
2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gu R, Li X, Yan X, Feng Z and Hu A:
Circular RNA circ_0032462 enhances osteosarcoma cell progression by
promoting KIF3B expression. Technol Cancer Res Treat: Nov 6, 2020
(Epub ahead of print). doi: 10.1177/1533033820943217.
|
|
9
|
Wang J, Zhu W, Tao G and Wang W: Circular
RNA circ-LRP6 facilitates Myc-driven tumorigenesis in esophageal
squamous cell cancer. Bioengineered. 11:932–938. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hall IF, Climent M, Quintavalle M, Farina
FM, Schorn T, Zani S, Carullo P, Kunderfranco P, Civilini E,
Condorelli G and Elia L: Circ_Lrp6, a Circular RNA enriched in
vascular smooth muscle cells, acts as a sponge regulating miRNA-145
function. Circ Res. 124:498–510. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Prats AC, David F, Diallo LH, Roussel E,
Tatin F, Garmy-Susini B and Lacazette E: Circular RNA, the key for
translation. Int J Mol Sci. 21(8591)2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tsitsipatis D and Gorospe M: Practical
guide forcircular RNA analysis: Steps, tips, and resources. Wiley
Interdiscip Rev RNA. 12(e1633)2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Saikishore R, Velmurugan P, Ranjithkumar
D, Latha R, Sathiamoorthi T, Arun A, Ravi AV and Sivakumar S: The
circular RNA-miRNA axis: A special RNA signature regulatory
transcriptome as a potential biomarker for OSCC. Mol Ther Nucleic
Acids. 22:352–361. 2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wen J, Liao J, Liang J, Chen X, Zhang B
and Chu L: Circular RNA HIPK3: A key circular RNA in a variety of
human cancers. Front Oncol. 10(773)2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Su Q and Lv X: Revealing new landscape of
cardiovascular disease through circular RNA-miRNA-mRNA axis.
Genomics. 112:1680–1685. 2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Gong C, Zhou X, Lai S, Wang L, Liu J,
Yanming X and Xu Y: Long noncoding RNA/Circular RNA-miRNA-mRNA axes
in Ischemia-Reperfusion injury. Biomed Res Int.
2020(8838524)2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wong RR, Abd-Aziz N, Affendi S and Poh CL:
Role of microRNAs in antiviral responses to dengue infection. J
Biomed Sci. 27(4)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Boca S, Gulei D, Zimta AA, Onaciu A, Magdo
L, Tigu AB, Ionescu C, Irimie A, Buiga R and Berindan-Neagoe I:
Nanoscale delivery systems for microRNAs in cancer therapy. Cell
Mol Life Sci. 77:1059–1086. 2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ebrahimi N, Aslani S, Babaie F,
Hemmatzadeh M, Pourmoghadam Z, Azizi G, Jadidi-Niaragh F and
Mohammadi H: MicroRNAs implications in the onset, diagnosis, and
prognosis of osteosarcoma. Curr Mol Med: Dec 3, 2020 (Epub ahead of
print).
|
|
21
|
Fu Y, Wang Y, Bi K, Yang L, Sun Y, Li B,
Liu Z, Zhang F, Li Y, Feng C and Bi Z: MicroRNA-208a-3p promotes
osteosarcoma progression via targeting PTEN. Exp Ther Med.
20(255)2020.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kushlinskii NE, Fridman MV and Braga EA:
Molecular mechanisms and microRNAs in osteosarcoma pathogenesis.
Biochemistry (Mosc). 81:315–328. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhou Y, Feng D, Gu X, Gao A and Liu Y: The
role and clinical significance of long noncoding RNA zinc finger
E-box-binding homeobox two antisense RNA 1 in promoting
osteosarcoma cancer cell proliferation, inhibiting apoptosis and
increasing migration by regulating miR-145. Anticancer Drugs.
32:168–177. 2021.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li X, Liu Y, Zhang X, Shen J, Xu R, Liu Y
and Yu X: Circular RNA hsa_circ_0000073 contributes to osteosarcoma
cell proliferation, migration, invasion and methotrexate resistance
by sponging miR-145-5p and miR-151-3p and upregulating NRAS. Aging
(Albany NY). 12:14157–14173. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Feng Y, Zhu J, Ou C, Deng Z, Chen M, Huang
W and Li L: MicroRNA-145 inhibits tumour growth and metastasis in
colorectal cancer by targeting fascin-1. Brit J Cancer.
110:2300–2309. 2014.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Tang M, Lin L, Cai H, Tang J and Zhou Z:
MicroRNA-145 downregulation associates with advanced tumor
progression and poor prognosis in patients suffering osteosarcoma.
Onco Targets Ther. 6:833–838. 2013.PubMed/NCBI View Article : Google Scholar
|
